WELLINGTON MANAGEMENT GROUP LLP - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$234,442,338
+5.9%
4,598,712
+3.8%
0.05%
+11.9%
Q2 2023$221,294,679
+82.3%
4,431,211
+36.8%
0.04%
+75.0%
Q1 2023$121,407,989
-28.2%
3,239,274
-8.2%
0.02%
-29.4%
Q4 2022$169,173,067
+303.0%
3,528,114
+101.7%
0.03%
+277.8%
Q3 2022$41,974,000
+1392.7%
1,748,921
+1253.4%
0.01%
+800.0%
Q2 2022$2,812,000
-89.8%
129,221
-88.7%
0.00%
-80.0%
Q1 2022$27,648,000
+0.8%
1,144,815
-0.7%
0.01%
+25.0%
Q4 2021$27,431,000
+4.1%
1,153,025
+11.1%
0.00%0.0%
Q3 2021$26,340,000
+33.3%
1,038,221
+18.2%
0.00%
+33.3%
Q2 2021$19,766,000
+0.2%
878,125
-12.0%
0.00%0.0%
Q1 2021$19,720,000
-26.6%
998,410
-1.2%
0.00%
-40.0%
Q4 2020$26,859,000
-50.5%
1,010,850
-7.9%
0.01%
-54.5%
Q3 2020$54,212,000
+42.9%
1,097,856
-8.5%
0.01%
+37.5%
Q2 2020$37,932,0001,200,0000.01%
Other shareholders
VAXCYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Abingworth LLP 4,168,718$90,711,00029.04%
Medicxi Ventures Management (Jersey) Ltd 3,774,956$82,142,00017.06%
Pivotal bioVenture Partners Investment Advisor LLC 832,166$18,108,0009.12%
GREAT POINT PARTNERS LLC 985,153$21,437,0005.14%
Kynam Capital Management, LP 723,781$15,749,0004.02%
Ghost Tree Capital, LLC 325,000$7,072,0003.68%
Frazier Life Sciences Management, L.P. 1,787,405$38,894,0003.67%
RA Capital Management 4,581,203$99,687,0002.66%
Opaleye Management Inc. 190,000$4,134,0001.86%
Soleus Capital Management, L.P. 370,650$8,065,0001.26%
View complete list of VAXCYTE INC shareholders